alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
APPLIANCE COMPUTING III, INC.

d/b/a SUREFIELD,

Plaintiff,

v.

REDFIN CORPORATION,

Defendant.

§

§

§

§

§

§

§

§

§

§

Case No. 6:20-cv-00376-ADA

ORDER GRANTING JOINT MOTION TO EXTEND 

SCHEDULING ORDER DEADLINES

Before the Court is Plaintiff Appliance Computing III, Inc. d/b/a Surefield’s and 

Defendant Redfin Corporation’s Joint Motion to Extend Scheduling Order Deadlines (the 

“Motion”). Having reviewed the Motion and finding good cause exists, the Court hereby 

GRANTS the Motion. 

IT IS THEREFORE ORDERED that the deadlines in the above-referenced cause are 

amended as follows:

Current Date New Date Item

03/25/2021 04/23/2021 Deadline to amend pleadings. A motion is not required 

unless the amendment adds patents or claims.

04/08/2021 05/07/2021 Deadline to serve Final Infringement and Invalidity 

Contentions. After this date, leave of Court is required 

for any amendment to Infringement or Invalidity 

contentions. This deadline does not relieve the Parties 

of their obligation to seasonably amend if new 

information is identified after initial contentions.

06/29/2021 07/29/2021 Close of Fact Discovery

07/02/2021 08/06/2021 Opening Expert Reports

UNITED STATES DISTRICT COURT 

FOR THE WESTERN DISTRICT OF TEXAS 

WACO DIVISION

Case 6:20-cv-00376-ADA Document 54 Filed 04/13/21 Page 1 of 2
2

08/02/2021 09/07/2021 Rebuttal Expert Reports

08/23/2021 09/21/2021 Close of Expert Discovery

08/30/2021 09/21/2021 Deadline to meet and confer to discuss narrowing the 

number of claims asserted and prior art references at 

issue. The parties shall file a report within 5 business 

days regarding the results of the meet and confer.

09/06/2021 09/27/2021 Dispositive motion deadline and Daubert motion 

deadline.

09/20/2021 10/04/2021 Serve Pretrial Disclosures (jury instructions, exhibits 

lists, witness lists, discovery and deposition

designations)

10/04/2021 10/11/2021 Serve objections to pretrial disclosures/rebuttal

disclosures

10/11/2021 10/17/2021 Serve objections to rebuttal disclosures and File

Motions in limine

10/18/2021 10/21/2021 File Joint Pretrial Order and Pretrial Submissions (jury

instructions, exhibits lists, witness lists, discovery and 

deposition designations); file oppositions to motions in 

limine

10/25/2021 10/25/2021

(unchanged)

Deadline to meet and confer regarding remaining

objections and disputes on motions in limine.

10/27/2021

3 business days 

before Final

Pretrial

Conference

10/27/2021

(unchanged)

3 business days 

before Final

Pretrial

Conference

File joint notice identifying remaining objections to 

pretrial disclosures and disputes on motions in limine.

11/01/2021 11/01/2021

(unchanged)

Final Pretrial Conference. The Court expects to set this 

date at the conclusion of the Markman Hearing.

11/16/2021 11/16/2021

(unchanged)

Jury Selection/Trial. The Court expects to set this date 

at the conclusion of the Markman Hearing.

ORDERED this ______ day of April, 2021. 

____________________________________

ALAN D. ALBRIGHT

UNITED STATES DISTRICT JUDGE

13th 

Case 6:20-cv-00376-ADA Document 54 Filed 04/13/21 Page 2 of 2
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Justice

###### Antitrust Division

                    Notice is hereby given that, on August 30, 2000, pursuant to section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301*et seq.*                     (“the Act”), Inter Company Collaboration for AIDS Drug Development has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership status. The notifications were filed for the purpose of extending the Act's provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Collaboration member Pfizer Inc., New York, NY, has acquired Warner-Lambert Co., Morris Plains, NJ by way of a merger. The combined company is called Pfizer Inc.                

No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and Inter Company Collaboration for AIDS Drug Development intends to file additional written notification disclosing all changes in membership.

                    On May 27, 1993, Inter Company Collaboration for AIDS Drug Development filed its original notification pursuant to section 6(a) of the Act. The Department of Justice published a notice in the                     **Federal Register**                     pursuant to section 6(b) of the Act on July 6, 1993 (58 FR 36223).                

                    The last notification was filed with the Department on May 26, 2000. A notice was published in the                     **Federal Register**                     pursuant to section 6(b) of the Act on September 13, 2000 (65 FR 55283).                

Constance K. Robinson,

Director of Operations, Antitrust Division.

[FR Doc. 00-25724  Filed 10-5-00; 8:45 am]

BILLING CODE 4410-11-M
#### The People of the State of New York, Respondent, v Thomas Diaz, Appellant.

Judgment, Supreme Court, Bronx County (Gerald Sheindlin, J.), rendered on May 17, 1988, convicting defendant of rape in the first degree and sentencing him to an indeterminate term of imprisonment of 2 to 6 years, is unanimously affirmed.

Application by appellant’s counsel to withdraw as counsel is granted. *(See, Anders v California,*386 US 738; *People v Saunders,*52 AD2d 833.) We have reviewed this record and agree with appellant’s assigned counsel that there are no nonfrivolous points which could be raised on this appeal.

Pursuant to CPL 460.20, defendant has the right to apply for leave to appeal to the Court of Appeals by making application to the Chief Judge of that court and by submitting such application to the clerk of that court or to a Justice of the Appellate Division of the Supreme Court of this department on reasonable notice to the respondent within 30 days after service of a copy of this order, with notice of entry.

Denial of the application for permission to appeal by the Judge or Justice first applied to is final and no new application may thereafter be made to any other Judge or Justice. Concur—Kupferman, J. P., Milonas, Rosenberger, Asch and Kassal, JJ.
EXHIBIT
32.1
 
 CERTIFICATION
 Pursuant
to 18 U.S.C. 1350
 (Section
906 of the Sarbanes-Oxley Act of 2002)
  In
connection with the Quarterly Report on Form 10-Q of Pervasip Corp. (the
"Company") for the quarter ended August 31, 2009, as filed with the Securities
and Exchange Commission on the date hereof (the "Report"), Paul H. Riss, as
Chief Executive Officer and Chief Financial Officer of the Company, hereby
certifies, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the
Sarbanes-Oxley Act of 2002, that:
  (1)         The
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934, as amended; and
  (2)         The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the
Registrant.
  Date:
      October 20, 2009
                                By:
                                /s/ Paul
      H. RissPaul
      H. Riss
                                  Chief
      Executive Officer and
                                    Chief
      Financial Officer
 
 This
certification accompanies each Report pursuant to § 906 of the Sarbanes-Oxley
Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley
Act of 2002, be deemed filed by the Company for purposes of §18 of the
Securities Exchange Act of 1934, as amended.
 
 A signed
original of this written statement required by Section 906 has been
provided to the Company and will be retained by the Company and furnished to the
Securities and Exchange Commission or its staff upon request.
ARMED SERVICES BOARD OF CONTRACT APPEALS Appeal of

-- ) ) Quimba Software, Inc. ) ) Under Contract Nos. F30602-03-C-O 185 ) FA8740-05-C-0085 ) APPEARANCE FORTHE APPELLANT:
APPEARANCES FORTHE GOVERNMENT: ASBCA No. 59197

Mr. Robert Dourandish

CEO E. Michael Chiaparas, Esq.

DCMA ChiefTrial Attorney Carol L. Matsunaga, Esq.

Senior Trial Attorney Srikanti Schaffner, Esq.

Trial Attorney Defense Contract Management Agency Carson, CA ORDER OF DISMISSAL Forreasons indicated by one or both parties, the Board is unable to proceed with disposition ofthe above appeal for an inordinate length oftime due to factors not within the control ofthe Board. Accordingly, the above appeal is hereby dismissed without prejudice pursuant to Board Rule l 8(b). Unless either party or the Board acts to reinstate the appeal within one year from the date ofthis Order, the dismissal shall be deemed with prejudice. Dated: 26 August 2014

# &~ Administrative Judge Vice Chairman Armed Services Board ofContract AppealsI certify that the foregoing is a true copy ofthe Order ofDismissal ofthe Armed Services Board ofContract Appeals in ASBCA No. 59197, Appeal ofQuimba Software, Inc., rendered in conformance with the Board's Charter. Dated:

2 JEFFREY D. GARDIN Recorder, Armed Services Board ofContract Appeals
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4779 Introduced in House (IH)]

112th CONGRESS
  2d Session
                                H. R. 4779

  To suspend temporarily the duty on 2,5-Bis(1,1-dimethylpropyl)-1,4-
                              benzenediol.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             April 25, 2012

Mr. Ross of Arkansas introduced the following bill; which was referred 
                   to the Committee on Ways and Means

_______________________________________________________________________

                                 A BILL

 
  To suspend temporarily the duty on 2,5-Bis(1,1-dimethylpropyl)-1,4-
                              benzenediol.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. 2,5-BIS(1,1-DIMETHYLPROPYL)-1,4-BENZENEDIOL.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``     9902.01.00        2,5-Bis(1,1-        Free            No change      No change      On or before     ''.
                          dimethylpropyl)-                                                  12/31/2015
                          1,4-benzenediol
                          (CAS No. 79-74-3)
                          (provided for in
                          subheading
                          2907.29.90)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
to goods entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
STEAM ELECTRIC CBI REPLACEMENT PAGE

EPA-HQ-OW-2009-0819

 DCN: SE03882A3

THE FOLLOWING HAS BEEN REMOVED BECAUSE IT 

CONTAINS CONFIDENTIAL BUSINESS INFORMATION 

(CBI) PER 40 CFR PART 2, SUBPART B.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the Sickle Cell Disease Advisory Committee.

                    The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such                           ( print page 59454)                        as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.                

*Name of Committee:*                         Sickle Cell Disease Advisory Committee.                    

*Date:*                         November 13, 2000.                    

*Time:*                         8:00 AM to 5:00 PM.                    

*Agenda:*                         Discussion of program policies and issues.                    

*Place:*                         National Institutes of Health, Two Rockledge Center, Conference Room 9112, 9116, 6701 Rockledge Drive, Bethesda, MD 20892.                    

*Contact Person:*                         Charles M Peterson, Director, Blood Diseases Program, Division of Blood Diseases and Resources, National Heart, Lung, and Blood Institute, NIH, Two Rockledge Center, Room 10158, MSC 7950, 6701 Rockledge Drive, Bethesda, MD 20892, 301/435-0050.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS)

Dated: September 27, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 00-25544 Filed 10-4-00; 8:45 am]

BILLING CODE 4140-01-M
|                                                                                           
|-------------------------------------------------------------------------------------------
|                                                                                           
|View History: Annual Download Data (XLS File)                                             
|View History: Annual                                                                       
|View History: Annual                                                                       
|View History:                                                                              
|                                                                                           
|Texas - RRC District 2 Onshore Natural Gas Plant Liquids, Proved Reserves (Million Barrels)
|                                                                                           
|                                                                                           
|Texas - RRC District 2 Onshore Natural Gas Plant Liquids, Proved Reserves (Million Barrels)
|                                                                                           

|Decade                                                                                                                            | Year-0 | Year-1 | Year-2 | Year-3 | Year-4 | Year-5 | Year-6 | Year-7 | Year-8 | Year-9
|--------------------------------------------------------------------------------------------------------------------------------- | ------ | ------ | ------ | ------ | ------ | ------ | ------ | ------ | ------ | ------
|1970's                                                                                                                            |        |        |        |        |        |        |        |        |        | 64    
|1980's                                                                                                                            | 64     | 88     | 75     | 99     | 103    | 100    | 89     | 102    | 92     | 72    
|1990's                                                                                                                            | 80     | 75     | 80     | 86     | 86     | 93     | 93     | 87     | 85     | 76    
|2000's                                                                                                                            | 72     | 67     | 71     | 69     | 79     | 91     | 90     | 111    | 105    |       
|- = No Data Reported;  -- = Not Applicable;  NA = Not Available;  W = Withheld to avoid disclosure of individual company data.
|                                                                                                                                 
|Release Date: 12/30/2022                                                                                                         
|Next Release Date: 12/29/2023
UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT
No. 06-4768

UNITED STATES OF AMERICA, Plaintiff - Appellee, versus RONDALE BERNARD SMITH, Defendant - Appellant. Appeal from the United States District Court for the Southern District of West Virginia, at Bluefield. David A. Faber, Chief District Judge. (1:03-cr-00225-ALL) Submitted: April 19, 2007 Decided: April 23, 2007 Before NIEMEYER, KING, and GREGORY, Circuit Judges. Affirmed by unpublished per curiam opinion. Mary Lou Newberger, Federal Public Defender, Jonathan D. Byrne, Appellate Counsel, David R. Bungard, Assistant Federal Public Defender, Charleston, West Virginia, for Appellant. Charles T. Miller, United States Attorney, John L. File, Assistant United States Attorney, Beckley, West Virginia, for Appellee. Unpublished opinions are not binding precedent in this circuit.- 2 - PER CURIAM: Rondale Bernard Smith appeals his 57-month prison sentence, imposed pursuant to his guilty plea to distribution of cocaine base, in violation of 21 U.S.C. § 841(a)(1) (2000). Smith’s only contention on appeal is that his sentence is unreasonable. When imposing a sentence after United States v. Booker , 543 U.S. 220 (2005), district courts must calculate the appropriate Guidelines range, consider the range in conjunction with other relevant factors under 18 U.S.C.A. § 3553(a) (West 2000 & Supp. 2006), and impose a reasonable sentence. United States v. Moreland , 437 F.3d 424, 432-33 (4th Cir.), cert. denied , 126 S. Ct. 2054 (2006). A sentence imposed within a properly calculated Guidelines range is presumptively reasonable. United States v. Green , 436 F.3d 449, 457 (4th Cir.), cert. denied , 126 S. Ct. 2309 (2006). Thus, Smith’s 57-month sentence is presumptively reasonable, because it is within both the properly calculated Guidelines range and the applicable statutory maximum. The record reflects that the district court complied with § 3553(a), and considered Smith’s personal history and circumstances in determining his sentence. Having reviewed the record and the briefs of the parties on appeal, we find the sentence reasonable. Therefore, we affirm Smith’s sentence. We dispense with oral argument because the facts and legal contentions are- 3 - adequately presented in the materials before the court and argument would not aid the decisional process. AFFIRMED
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5094 Introduced in House (IH)]

112th CONGRESS
  2d Session
                                H. R. 5094

  To reduce temporarily the duty on certain AC electric motors of an 
  output exceeding 74.6 W equipped with a capacitor rated not over 4 
                              microfarads.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             April 27, 2012

 Mr. Gerlach introduced the following bill; which was referred to the 
                      Committee on Ways and Means

_______________________________________________________________________

                                 A BILL

 
  To reduce temporarily the duty on certain AC electric motors of an 
  output exceeding 74.6 W equipped with a capacitor rated not over 4 
                              microfarads.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. CERTAIN AC ELECTRIC MOTORS OF AN OUTPUT EXCEEDING 74.6 W 
              EQUIPPED WITH A CAPACITOR RATED NOT OVER 4 MICROFARADS.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``     9902.01.00      AC electric motors  1%           No change        No change        On or before 12/  ''.
                        of an output                                                       31/2015.......
                        exceeding 74.6 W
                        but not exceeding
                        105 W, single
                        phase; each
                        equipped with a
                        capacitor rated
                        not over 4
                        microfarads, a
                        rotary speed
                        control mechanism
                        and a motor mount
                        cooling ring
                        (provided for in
                        subheading
                        8501.40.40)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
to goods entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
----

Non-opposition to a notified concentration

(Case COMP/M.4237 — Bouygues/Alstom)

(2006/C 151/04)

(Text with EEA relevance)

On 20 June 2006, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004. The full text of the decision is available only in French and will be made public after it is cleared of any business secrets it may contain. It will be available:

----